Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis. [electronic resource]
- Breast cancer research : BCR 2008
- R104 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1465-542X
10.1186/bcr2208 doi
Animals Annexin A5--metabolism Antimetabolites, Antineoplastic--pharmacology Apoptosis--drug effects Blotting, Western Breast Neoplasms--drug therapy Buthionine Sulfoximine--pharmacology Cell Proliferation--drug effects Cytochromes c--metabolism Drug Resistance, Neoplasm Drug Synergism Estradiol--pharmacology Estrogens--deficiency Female Forkhead Transcription Factors--physiology Glutathione--metabolism Humans Immunoenzyme Techniques In Situ Nick-End Labeling JNK Mitogen-Activated Protein Kinases--metabolism Membrane Potential, Mitochondrial--drug effects Mice Mice, Nude Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors RNA, Messenger--genetics RNA, Small Interfering--pharmacology Reverse Transcriptase Polymerase Chain Reaction Tumor Cells, Cultured bcl-2-Associated X Protein--metabolism